Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
2002 12
2003 17
2004 14
2005 16
2006 15
2007 18
2008 21
2009 18
2010 21
2011 39
2012 38
2013 41
2014 48
2015 56
2016 59
2017 80
2018 66
2019 107
2020 147
2021 131
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

870 results
Results by year
Filters applied: . Clear all
Page 1
Adjuvants for Coronavirus Vaccines.
Liang Z, Zhu H, Wang X, Jing B, Li Z, Xia X, Sun H, Yang Y, Zhang W, Shi L, Zeng H, Sun B. Liang Z, et al. Among authors: shi l. Front Immunol. 2020 Nov 6;11:589833. doi: 10.3389/fimmu.2020.589833. eCollection 2020. Front Immunol. 2020. PMID: 33240278 Free PMC article. Review.
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.
Balar AV, Galsky MD, Rosenberg JE, Powles T, Petrylak DP, Bellmunt J, Loriot Y, Necchi A, Hoffman-Censits J, Perez-Gracia JL, Dawson NA, van der Heijden MS, Dreicer R, Srinivas S, Retz MM, Joseph RW, Drakaki A, Vaishampayan UN, Sridhar SS, Quinn DI, Durán I, Shaffer DR, Eigl BJ, Grivas PD, Yu EY, Li S, Kadel EE 3rd, Boyd Z, Bourgon R, Hegde PS, Mariathasan S, Thåström A, Abidoye OO, Fine GD, Bajorin DF; IMvigor210 Study Group. Balar AV, et al. Among authors: li s. Lancet. 2017 Jan 7;389(10064):67-76. doi: 10.1016/S0140-6736(16)32455-2. Epub 2016 Dec 8. Lancet. 2017. PMID: 27939400 Free PMC article. Clinical Trial.
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.
Rini BI, Powles T, Atkins MB, Escudier B, McDermott DF, Suarez C, Bracarda S, Stadler WM, Donskov F, Lee JL, Hawkins R, Ravaud A, Alekseev B, Staehler M, Uemura M, De Giorgi U, Mellado B, Porta C, Melichar B, Gurney H, Bedke J, Choueiri TK, Parnis F, Khaznadar T, Thobhani A, Li S, Piault-Louis E, Frantz G, Huseni M, Schiff C, Green MC, Motzer RJ; IMmotion151 Study Group. Rini BI, et al. Among authors: li s. Lancet. 2019 Jun 15;393(10189):2404-2415. doi: 10.1016/S0140-6736(19)30723-8. Epub 2019 May 9. Lancet. 2019. PMID: 31079938 Clinical Trial.
Chinese guideline on sublingual immunotherapy for allergic rhinitis and asthma.
Li H, Chen S, Cheng L, Guo Y, Lai H, Li Y, Lin X, Liu Z, Qiu Q, Shao J, Shi L, Tian M, Wang C, Wang H, Wang X, Wei Q, Wei Y, Xiang L, Yang Q, Zhao C, Zhang H, Zhi Y, Gao J, Li Q, Liu J, Wang K, Zhou W, Zhang L; Chinese Society of Allergy (CSA). Li H, et al. Among authors: shi l. J Thorac Dis. 2019 Dec;11(12):4936-4950. doi: 10.21037/jtd.2019.12.37. J Thorac Dis. 2019. PMID: 32030209 Free PMC article. Review. No abstract available.
Profiles of COVID-19 clinical trials in the Chinese Clinical Trial Registry.
Xu P, Xing X, Yu K, Lv Z, Cui H, Shi Y, Chang T, Zhang D, Zhang Y, Wang K, Lu J, Huang Q, Li X, Cui Y, Shi L, Wang T, Niu J, Wang J. Xu P, et al. Among authors: shi l. Emerg Microbes Infect. 2020 Dec;9(1):1695-1701. doi: 10.1080/22221751.2020.1791736. Emerg Microbes Infect. 2020. PMID: 32615862 Free PMC article. Review.
870 results